Koers DexCom, Inc. Wiener Boerse
Aandelen
DXCM
US2521311074
Medische apparatuur, benodigdheden & distributie
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
105,7 EUR | -4,41% | -3,13% | -5,91% |
Omzet 2024 * | 4,33 mld. 4,01 mld. | Omzet 2025 * | 5,15 mld. 4,77 mld. | Marktkapitalisatie | 46,05 mld. 42,64 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 728 mln. 674 mln. | Nettowinst (verlies) 2025 * | 906 mln. 839 mln. | EV/omzet 2024 * | 11 x |
Nettoschuld 2024 * | 1,43 mld. 1,33 mld. | Nettoschuld 2025 * | 994 mln. 921 mln. | EV/omzet 2025 * | 9,13 x |
K/w-verhouding 2024 * |
64,1
x | K/w-verhouding 2025 * |
52,4
x | Werknemers | 9.550 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 96,62% |
Recentste transcriptie over DexCom, Inc.
1 dag | -4,41% | ||
1 week | -3,13% | ||
Lopende maand | -3,13% | ||
1 maand | -12,44% | ||
3 maanden | -14,30% | ||
6 maanden | -3,77% | ||
Lopend jaar | -5,91% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Kevin Sayer
CEO | Chief Executive Officer | 66 | 01-11-07 |
Jereme Sylvain
DFI | Director of Finance/CFO | 44 | 01-09-18 |
Chief Tech/Sci/R&D Officer | 47 | 01-10-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Nick Augustinos
BRD | Director/Board Member | 65 | 20-11-09 |
Mark Foletta
BRD | Director/Board Member | 63 | 19-11-14 |
Eric Topol
BRD | Director/Board Member | 69 | 09-07-09 |
Datum | Koers | Variatie |
---|---|---|
07-06-24 | 106,6 | +0,83% |
06-06-24 | 105,7 | -4,41% |
05-06-24 | 110,6 | +4,38% |
04-06-24 | 106 | -1,36% |
03-06-24 | 107,4 | -1,58% |
slotkoers Wiener Boerse, 06 juni 2024
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,26% | 187 mld. | |
+2,05% | 110 mld. | |
-1,31% | 69,54 mld. | |
+14,65% | 46,37 mld. | |
+7,97% | 42,54 mld. | |
+18,60% | 30,72 mld. | |
+16,92% | 25,62 mld. | |
-6,87% | 23,32 mld. | |
-10,63% | 22,92 mld. |
- Beurs
- Aandelen
- Koers DXCM
- Koers DXCM